Compound Report Overview
Compound Name:
()-4-ALPHA(R)-4-ALLYL-2(S)5(R)-DIMETHYLPIPERAZIN-1-YL-3-METHOXYBENZYL-N-ETHYL-N-METHYLBENZAMIDE DIHYDROCHLORIDE
Compound Identifier:
706302
Development Status:
Clinical Phase IIIII
SMILES:
CCN(C)C(O)c1ccc(cc1)C(N2CC(C)N(CCC)CC2C)c3cccc(OC)c3